Clinical Trial Update: Efficacy and Safety of QLG1090 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is planned to compare QLG1090 with Rybelsus as an add-on to metformin in adults with Type 2 diabetes; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• QLG1090
• Rybelsus (semaglutide)
• metformin (metformin)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: NOT_YET_RECRUITING